aminolevulinic acid has been researched along with Genetic Predisposition in 7 studies
Aminolevulinic Acid: A compound produced from succinyl-CoA and GLYCINE as an intermediate in heme synthesis. It is used as a PHOTOCHEMOTHERAPY for actinic KERATOSIS.
5-aminolevulinic acid : The simplest delta-amino acid in which the hydrogens at the gamma position are replaced by an oxo group. It is metabolised to protoporphyrin IX, a photoactive compound which accumulates in the skin. Used (in the form of the hydrochloride salt)in combination with blue light illumination for the treatment of minimally to moderately thick actinic keratosis of the face or scalp.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Positive family history, high genetic susceptibility, smoking and increased BMI had an OR of 21." | 1.42 | Improved performance of epidemiologic and genetic risk models for rheumatoid arthritis serologic phenotypes using family history. ( Alfredsson, L; Askling, J; Chen, CY; Costenbader, KH; Hiraki, LT; Jiang, X; Karlson, EW; Klareskog, L; Malspeis, S; Sparks, JA, 2015) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (42.86) | 29.6817 |
| 2010's | 4 (57.14) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wan, H | 1 |
| Wu, J | 1 |
| Sun, P | 1 |
| Yang, Y | 1 |
| Sparks, JA | 1 |
| Chen, CY | 1 |
| Jiang, X | 1 |
| Askling, J | 1 |
| Hiraki, LT | 1 |
| Malspeis, S | 1 |
| Klareskog, L | 1 |
| Alfredsson, L | 1 |
| Costenbader, KH | 1 |
| Karlson, EW | 1 |
| Elenbaas, JS | 1 |
| Maitra, D | 1 |
| Liu, Y | 2 |
| Lentz, SI | 1 |
| Nelson, B | 1 |
| Hoenerhoff, MJ | 1 |
| Shavit, JA | 1 |
| Omary, MB | 1 |
| Billoo, AG | 1 |
| Lone, SW | 1 |
| Srivastava, K | 1 |
| Srivastava, A | 1 |
| Mittal, B | 1 |
| Caty, V | 1 |
| Viau, G | 1 |
| Bissonnette, R | 1 |
| Kuo, HC | 1 |
| Lee, MJ | 1 |
| Chuang, WL | 1 |
| Huang, CC | 1 |
7 other studies available for aminolevulinic acid and Genetic Predisposition
| Article | Year |
|---|---|
Investigation of delta-aminolevulinic acid dehydratase polymorphism affecting hematopoietic, hepatic and renal toxicity from lead in Han subjects of southwestern China.
Topics: Adult; Aminolevulinic Acid; Asian People; Biomarkers; China; Creatinine; Cross-Sectional Studies; Fe | 2014 |
Improved performance of epidemiologic and genetic risk models for rheumatoid arthritis serologic phenotypes using family history.
Topics: Aged; Alcohol Drinking; Aminolevulinic Acid; Area Under Curve; Arthritis, Rheumatoid; Autoantibodies | 2015 |
A precursor-inducible zebrafish model of acute protoporphyria with hepatic protein aggregation and multiorganelle stress.
Topics: Aminolevulinic Acid; Animals; Deferoxamine; Disease Models, Animal; Genetic Predisposition to Diseas | 2016 |
A family with acute intermittent porphyria.
Topics: Adolescent; Aminolevulinic Acid; Family; Female; Genetic Predisposition to Disease; Humans; Pedigree | 2008 |
Polymorphisms in ERCC2, MSH2, and OGG1 DNA repair genes and gallbladder cancer risk in a population of Northern India.
Topics: Aminolevulinic Acid; Case-Control Studies; DNA Glycosylases; Female; Gallbladder Neoplasms; Gallston | 2010 |
Multiple large surface photodynamic therapy sessions with topical methylaminolaevulinate in PTCH heterozygous mice.
Topics: Aminolevulinic Acid; Animals; Carcinoma, Basal Cell; Female; Genetic Predisposition to Disease; Hete | 2006 |
Acute intermittent porphyria with peripheral neuropathy: a follow-up study after hematin treatment.
Topics: Adult; Aminolevulinic Acid; DNA Mutational Analysis; Female; Follow-Up Studies; Genetic Markers; Gen | 2007 |